IDH2 and astrocytoma (excluding glioblastoma): In our study, patients with histopathological features of glioblastoma and IDH-mutant biology (now classified as “astrocytoma, IDH-mutant”) were significantly younger with a median age at diagnosis of 36.48 years compared to patients with IDH-wildtype (median age at diagnosis 67.04 years).